David Kirske, EVP, Chief Financial Officer at CTI BIOPHARMA CORP (CTIC), sold 81,063 shares at $6.00 ($487K) on 2022-12-30, disclosed to the SEC on 2023-01-03.
Open-market sale of $487k CTIC by EVP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.00 | 13,174 | $79K | 16.2% |
| 2 | $6.00 | 12,000 | $72K | 14.8% |
| 3 | $6.01 | 800 | $5K | 1.0% |
| 4 | $6.01 | 1,047 | $6K | 1.3% |
| 5 | $6.01 | 27,021 | $162K | 33.4% |
| 6 | $6.01 | 27,021 |
| $162K |
| 33.4% |
| Total | $6.01 avg | 81,063 | $487K | 100% |
| Filing → |
| CTIC | SELL | 2022-10-06 | $13K | — | Filing → |
| CTIC | SELL | 2022-10-03 | $1.7M | — | Filing → |
| CTIC | SELL | 2022-09-20 | $272K | — | Filing → |